Primary chemotherapy with gemcitabine, liposomal doxorubicin and docetaxel in patients with locally advanced breast cancer: results of a phase I trial-Reference-Cited by-同舟云学术

Primary chemotherapy with gemcitabine, liposomal doxorubicin and docetaxel in patients with locally advanced breast cancer: results of a phase I trial

Published:2005-01 Issue:1 Volume:16 Page:21-29
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:Anti-Cancer Drugs

Author:

Schmid Peter,Krocker Jutta,Schulz Carsten-Oliver,Michniewicz Katarzyna,Dieing Annette,Eggemann Holm,Heilmann Volker,Blohmer Jens-Uwe,Sezer Orhan,Elling Dirk,Possinger Kurt

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical observation of liposomal doxorubicin on liver and renal function in patients with breast cancer;Toxicology Research;2023-08-26

2. Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer;Cancers;2021-09-01

3. Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: a randomized controlled trial;BMC Cancer;2021-01-11

4. Use of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practice;Journal of Zhejiang University-SCIENCE B;2017-01

5. Trans-arterial chemoperfusion for the treatment of liver metastases of breast cancer and colorectal cancer: Clinical results in palliative care patients;World Journal of Clinical Oncology;2017